Navigation Links
Bayer Employees Named Rising Stars by Healthcare Businesswomen's Association
Date:5/3/2012

MORRISTOWN, N.J. and TARRYTOWN, N.Y., May 3, 2012 /PRNewswire/ -- Bayer HealthCare is pleased to announce two employees have been named Rising Stars by The Healthcare Businesswomen's Association (HBA). They were honored at the annual HBA Woman of the Year luncheon in New York City on May 3.

Mary Puncochar, Area Sales Manager, U.S. Sales and Marketing, Bayer HealthCare Diabetes Care, and Laura Schwieterman, Senior Brand Manager, U.S. Marketing, Bayer HealthCare Consumer Care, were the recipients. The honor is bestowed upon professionals who contribute significantly to their organizations, exemplify leadership, are role models for others and exhibit dedication to the healthcare industry.

Mary was honored for creating several programs to aid sales representatives and managers in achieving their career goals, including a new mentorship program that has been adopted nationwide.  "Mary's abilities to develop leaders, manage and lead change and inspire others continue to strengthen the organization," said Michael E. Mathews, Region Head, North America Bayer Diabetes Care and Senior Vice President, Bayer HealthCare.

Laura was recognized for leading the Alka-Seltzer Plus® team to reach a decade-long sales goal and launching a new product in record time. "Laura exemplifies a Rising Star through her business results and leadership of initiatives that better the organization," said Timothy Hayes, Senior Vice President of Bayer HealthCare Consumer Care's North American Region and Head of Global Business Development.

Both women act as leaders and mentors within the Bayer HealthCare organization by championing the national Women's Leadership Initiative (WLI) program, designed to cultivate successful women leaders to strengthen business results.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.

BAYER and the Bayer Cross are registered trademarks of Bayer. 

 

 


'/>"/>
SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. FDA Clears Bayer HealthCares CONTOUR® Next EZ Blood Glucose Monitoring System
2. Piramal Healthcare Limited Acquires Molecular Imaging Development Portfolio of Bayer Pharma
3. Bayer Expands Its Hemophilia Leadership Development Program
4. Phase III Data Show Bayers Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Thera
5. Phase 3 Data Show Bayers Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Therapi
6. Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
7. Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): Phase III Data on Bayers Investigational Compound Regorafenib (BAY 73-4506) in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Or
8. Intendis, Inc. Changes Name to Bayer HealthCare
9. Bayers Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis
10. Bayers Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
11. Bayer HealthCare LLC Stops Trademark Infringement by Indian Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):